Frans Opdam

I started working at the Netherlands Cancer Institute in 2012 and mainly focus on oncological treatment in trial form: research that aims to find the proper, safe doses of new cancer drugs. These new cancer drugs usually focus on specific proteins in the tumors and can take us one step closer to personalized pharmacotherapy.